Last Update 17:49
Sunday, 07 March 2021

Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax

Ad5-nCoV is a vaccine candidate co-developed by CanSino Biologics and a Chinese military-backed research unit

Reuters , Monday 7 Dec 2020
Share/Bookmark
Views: 1134
Share/Bookmark
Views: 1134
Latest

© 2010 Ahram Online.